Bank of America’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Bank of America’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,050	Closed	-$82K	–	7674
2016 Q3	$82K	Sell	2,050 -100	-5%	-$2.47K	﹤0.01%	5523
2016 Q2	$36K	Buy	2,150 +1,900	+760%	+$25.6K	﹤0.01%	5986
2016 Q1	$3K	Sell	250 -1,286	-84%	-$17.2K	﹤0.01%	6745
2015 Q4	$23K	Sell	1,536 -9	-0.6%	-$137	﹤0.01%	6379
2015 Q3	$25K	Sell	1,545 -526	-25%	-$8.54K	﹤0.01%	6247
2015 Q2	$34K	Buy	+2,071	New	+$34K	﹤0.01%	6135

Bank of America's CYNA Position: Q4 2016 in Review

Bank of America sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 2,050 shares — an estimated $82K sold.

Bank of America first reported a position in CYNA in Q2 2015 and held it in 6 quarters. The position peaked at $82K in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

Bank of America reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
Bank of America sold 2,050 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $82K.
Bank of America first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 6 quarters.
Bank of America's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $82K in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.